Collegium Pharmaceutical Overview
Collegium Pharmaceutical Target Price
Analysts' 12-month price predictions for COLL.
Get informed when a big investor buys or sells
+ FollowShare Price
$37.03
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-02-10 | Truist FinancialLes Sulewski | $58 |  56.6% upside |  |
| 2026-01-09 | Barclays | $56 | 51.2% upside | |
| 2026-01-09 | H.C. Wainwright | $60 | 62% upside | |
| 2026-01-07 | Truist Financial | $55 | 48.5% upside | |
| 2025-12-08 | Barclays | $58 | 56.6% upside | |
| 2025-02-04 | Piper SandlerDavid Amsellem | $36 |  2.8% downside | |
| 2024-11-11 | JefferiesGlen Santangelo | $40 | 8% upside | |
| 2024-09-04 | H.C. WainwrightOren Livnat | $50 | 35% upside | |
| 2024-08-09 | Piper SandlerDavid Amsellem | $37 | 0.1% downside | |
| 2024-07-30 | H.C. WainwrightOren Livnat | $47 | 26.9% upside | |
| 2024-06-07 | JefferiesGlen Santangelo | $44 | 18.8% upside | |
| 2024-05-10 | Piper SandlerDavid Amsellem | $39 | 5.3% upside | |
| 2023-01-05 | Needham | $35 | 5.5% downside | |